Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
The optimism led by a decent first-quarter 2024 performance and its product development activities are expected to contribute further. However, stiff competition and macroeconomic concerns persist. In the year-to-date period, this Zacks Rank #3 (Hold) stock has lost 87.8% against 5.4% growth of the industry. The S&P 500 Composite also gained 15% in the same time frame. The renowned global provider of sequencing systems has a market capitalization of $373.1 million. The company projects 18% growth for 2024 and expects to maintain a strong performance in the future. PacBio's earnings surpassed the Zacks Consensus Estimate in three of the trailing four quarters, with third-quarter earnings being in line, delivering an average surprise of 11.6%. Image Source: Zacks Investment Research Let's delve deeper. Focus on R&D: We are optimistic about PacBio's continued R&D efforts that focus on programs to develop new and existing platforms, as well as increasing throughput and decreasin
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Pacific Biosciences of California, Inc (PACB): A Good Buy According to Analysts? [Yahoo! Finance]Yahoo! Finance
- Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best Practices [Yahoo! Finance]Yahoo! Finance
- Form Bio and PacBio Announce Collaboration to Launch New Resources Set to Transform AAV Design and Analysis Best PracticesAccesswire
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
PACB
Earnings
- 5/9/24 - In-Line
PACB
Sec Filings
- 6/20/24 - Form 4
- 6/20/24 - Form 4
- 6/20/24 - Form 4
- PACB's page on the SEC website